SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain’s Fast 50 List
13 déc. 2024 10h00 HE
|
SPR Therapeutics, Inc.
SPR Therapeutics ranked first on the Crain’s Cleveland Business Fast 50 list of rapidly growing, privately held companies in Northeast Ohio.
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
23 juin 2024 10h00 HE
|
SPR Therapeutics, Inc.
Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
14 mai 2024 18h33 HE
|
SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
13 mai 2024 14h16 HE
|
SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT® PNS System for Low Back Pain
12 déc. 2023 11h48 HE
|
SPR Therapeutics, Inc.
SPR Therapeutics Announces Completion of Enrollment in the RESET Clinical Trial of the SPRINT PNS System for Low Back Pain
SPR Therapeutics Announces 20,000th Patient Implant of SPRINT® PNS System
22 août 2023 10h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...
Real-World Data from Over 6,100 Patients Corroborates Significant Pain Reduction from Prior Prospective Studies for Patients Treated with SPRINT® PNS
17 mai 2023 10h16 HE
|
SPR Therapeutics, Inc.
CLEVELAND, May 17, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics announced the publication of a comprehensive real-world retrospective data analysis of over 6,100 patients demonstrating significant...
SelectHealth Initiates Peripheral Nerve Stimulation (PNS) Coverage to Support Patient Need for Effective Non-opioid Pain Treatment
04 mai 2023 11h07 HE
|
SPR Therapeutics, Inc.
CLEVELAND, May 04, 2023 (GLOBE NEWSWIRE) -- SelectHealth, a non-profit health plan with over one million members, has demonstrated leadership amid the opioid crisis by creating one of the first...
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
25 avr. 2023 10h00 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
SPR Therapeutics Receives 510(k) Clearance of Technological Advancements and an Expanded Intended Patient Population for the SPRINT® PNS System
03 févr. 2023 15h32 HE
|
SPR Therapeutics, Inc.
CLEVELAND, Feb. 03, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic...